Skip to main content
The science that saves lives rarely happens in isolation

Work with us

The science that saves lives rarely happens in isolation

At the Baker Heart and Diabetes Institute, we bring together researchers, clinicians, industry and community to tackle heart disease, diabetes and obesity — from the laboratory to the clinic and beyond.

Since 1926, we've been building partnerships that accelerate discovery and turn research into real change — for patients, communities and health systems. Whether you're from industry, academia, government or the philanthropic sector, there's a place for you in what we do.

Why partner with the Baker Institute?

We offer something that's genuinely rare: a research environment where world-class science, clinical access and translational know-how sit side-by-side.

Our home within Melbourne's Alfred Research Alliance precinct connects us directly to Alfred Health and a catchment of more than 700,000 patients. This means the research we do is grounded in real clinical need — and the partnerships we form are positioned to deliver real-world impact, faster.

We bring together expertise across the full research pipeline, from discovery science through to clinical trials, commercialisation and public health. Whatever stage you're at, we can meet you there.

Partnership pathways

Industry and commercialisation
Access world-class expertise, clinical environments and a clear pathway from discovery to market.
Academic and research partnerships
Join a globally connected research community with formal ties to Oxford, Cambridge, Melbourne, Monash and more.
Health services
Co-design clinically relevant research programs that strengthen care and improve outcomes for patients.
Contract research and services
Get access to our world-class research expertise, advanced clinical capabilities, and cutting-edge preclinical and technological platforms.
Philanthropic partnerships
Invest in science that saves lives. Your support powers the breakthroughs the world needs most.
Corporate partnerships
A partnership with the Baker Heart and Diabetes Institute is not just a collaboration; it's a transformative, evidence-based journey where possibilities know no bounds.
Trusts and foundations
We always welcome partnerships with philanthropic trusts and foundations to support our vision.

Looking for career opportunities?

The Baker Institute is only as strong as the people behind it. If you're driven by purpose and passionate about making a difference in cardiovascular and diabetes research, we want to hear from you.

We have opportunities for researchers, clinicians, professional services staff and students at all career stages.

View our current career opportunities

Browse our student research opportunities

Our partnerships

Boehringer Ingelheim and Eli Lilly Australia & New Zealand Diabetes Alliance
Boehringer Ingelheim and Eli Lilly
We are proud to partner with the Boehringer Ingelheim and Eli Lilly Australia & New Zealand Diabetes Alliance
Heartbeat Victoria
Heartbeat Victoria
We have partnernered with Heartbeat Victoria through our Community Engagement Group
Novartis
Novartis
We are proud to partner with Novartis Australia and New Zealand, with our shared values aimed at improving the heart health of Australians
Edwards Lifesciences
Edwards Lifesciences
We have partnered with Edwards Lifesciences to support for emerging technologies and promote heart health to the broader community
HeartWest
HeartWest
We have established a unique, community-based research facility in the HeartWest cardiology service located in Hoppers Crossing, Victoria

Our academic affiliations

Alfred Research Alliance
Alfred Research Alliance
We are a member of the Alfred Research Alliance and have advanced collaborative relationships with its members
Cambridge University
Cambridge University
We have partnered with Cambridge University to establish the Cambridge Baker Strategic Partnership for Systems Genomics
Deakin University
Deakin University
The Institute’s partnership with Deakin University focuses on shared research expertise in the areas of diabetes and cardiovascular risk and control, physical activity and sedentary behaviour
La Trobe University
La Trobe University
The Baker Institute and La Trobe University have established several research collaborations in the areas of cardiovascular disease and diabetes, building on the complementary research strengths of both organisations
Monash Partners
Monash Partners
We are one of the eight member organisations of Monash Partners, an innovative Australian health industry, research and educational collaboration
Monash University
Monash University
The Institute and Monash University have shared expertise and interests across a range of research areas including diabetes, epidemiology, metabolomics, and cardiovascular disease
Swinburne University
Swinburne University of Technology
The Institute’s partnership with Swinburne University of Technology acknowledges the collaboration that already occurs between our two organisations
The University of Melbourne
The University of Melbourne
The Institute is strengthening ties with the University of Melbourne in key areas of shared expertise

Our memberships

As one of Australia's leading independent medical research institutes, the Baker Institute is committed to playing a significant leadership role in health and medical research. One way that we do that is by being an active member of peak health and scientific leadership organisations. The Institute is proud to be a member of the following groups:

Association of Australian Medical Research Institutes (AAMRI)
The Institute is a member of AAMRI and works closely with the association to advocate on issues related to medical research in Australia.
Australian Cardiovascular Alliance (ACvA)
The Institute is a founding member of this Alliance, Australia’s peak leadership body for the advancement of research into heart, stroke and vascular disease that is lobbying as a united voice to advocate for critical attention in this space.
CAD Frontiers
CAD Frontiers is an Australian led, international team at the cutting edge of coronary artery disease research and clinical practice expertise.